Tissue Array Specification Sheet


Product Name: Multiple organ diseased tissue array, 30 cases/60 cores, replaced by MC801 3 Slides Price: $277, 5 Slides Price: $452
Array Panel: Multiple organ diseased tissue microarray, including 30 cases of 11 types of organs carcinoma (brain, breast, colon, esophagus, kidney, liver, lung, stomach, striated muscles, tongue and uterus), duplicate cores per case
Cat No. Cases Layout Cores Diameter Thickness Standard IHC
BC00012  30 6 x 10 60 1.5 mm 5 µm Anti-Cytokeratin (CK) confirmed

Microarray Panel Display

 
12345678910
A Liv Sto Eso Kid Bra Ute Ute Col Bre Lun
B Liv Sto Eso Kid Bra Ute Ute Col Bre Lun
C Liv Sto Eso Kid Bra Ute Str Col Bre Lun
D Liv Sto Eso Kid Bra Ute Str Col Bre Lun
E Liv Sto Eso Kid Bra Ute Ton Col Bre Lun
F Liv Sto Eso Kid Bra Ute Ton Col Bre Lun
Legend: Bra - Brain, Bre - Breast, Col - Colon, Eso - Esophagus, Kid - Kidney, Liv - Liver, Lun - Lung, Sto - Stomach, Str - Striated muscles, Ton - Tongue, Ute - Uterus

- Malignant tumor, - Benign tumor, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Type †
A1 1 F 55 Liver Hepatocellular carcinoma III Malignant
A2 2 F 55 Stomach Mucous cell carcinoma III Malignant
A3 3 M 65 Esophagus Squamous cell carcinoma III Malignant
A4 4 M 72 Kidney Clear cell carcinoma - Malignant
A5 5 F 29 Brain Syncytial meningioma - Benign
A6 6 F 55 Uterus Adenocarcinoma III Malignant
A7 7 F 24 Uterus Alveolar Rhabdomyosarcoma - Malignant
A8 8 M 37 Colon Adenocarcinoma II Malignant
A9 9 F 48 Breast Infiltrating duct carcinoma - Malignant
A10 10 M 70 Lung Adenocarcinoma III Malignant
B1 11 F 55 Liver Hepatocellular carcinoma III Malignant
B2 12 F 55 Stomach Mucous cell carcinoma III Malignant
B3 13 M 65 Esophagus Squamous cell carcinoma - Malignant
B4 14 M 72 Kidney Clear cell carcinoma - Malignant
B5 15 F 29 Brain Syncytial meningioma - Benign
B6 16 F 55 Uterus Inflammatory necrosis tissue - Malignant
B7 17 F 24 Uterus Alveolar Rhabdomyosarcoma - Malignant
B8 18 M 37 Colon Adenocarcinoma II Malignant
B9 19 F 48 Breast Infiltrating duct carcinoma - Malignant
B10 20 M 70 Lung Adenosquamous carcinoma - Malignant
C1 21 F 32 Liver Hepatocellular carcinoma I Malignant
C2 22 M 57 Stomach Adenocarcinoma III Malignant
C3 23 M 75 Esophagus Squamous cell carcinoma III Malignant
C4 24 M 72 Kidney Clear cell carcinoma - Malignant
C5 25 M 27 Brain Fibrous meningioma - Benign
C6 26 F 50 Uterus Adenocarcinoma I Malignant
C7 27 M 7 Striated muscles Alveolar rhabdomyosarcoma - Malignant
C8 28 M 62 Colon Adenocarcinoma II Malignant
C9 29 F 42 Breast Fibrofatty tissue - Malignant
C10 30 M 60 Lung Adenocarcinoma III Malignant
D1 31 F 32 Liver Hepatocellular carcinoma I Malignant
D2 32 M 57 Stomach Adenocarcinoma III Malignant
D3 33 M 75 Esophagus Squamous cell carcinoma III Malignant
D4 34 M 72 Kidney Clear cell carcinoma - Malignant
D5 35 M 27 Brain Fibrous meningioma - Benign
D6 36 F 50 Uterus Adenocarcinoma I Malignant
D7 37 M 7 Striated muscles Alveolar rhabdomyosarcoma - Malignant
D8 38 M 62 Colon Adenocarcinoma II Malignant
D9 39 F 42 Breast Fibrofatty tissue - Malignant
D10 40 M 60 Lung Adenocarcinoma III Malignant
E1 41 M 63 Liver Hepatocellular carcinoma II Malignant
E2 42 M 74 Stomach Adenocarcinoma III Malignant
E3 43 M 62 Esophagus Squamous cell carcinoma II Malignant
E4 44 M 54 Kidney Clear cell carcinoma - Malignant
E5 45 F 47 Brain Syncytial meningioma - Benign
E6 46 F 42 Uterus Smooth muscle and phlegmasia - Normal
E7 47 M 38 Tongue Adenoid cystic carcinoma - Malignant
E8 48 M 58 Colon Adenocarcinoma I Malignant
E9 49 F 65 Breast Infiltrating duct carcinoma - Malignant
E10 50 M 57 Lung Adenocarcinoma III Malignant
F1 51 M 63 Liver Hepatocellular carcinoma II Malignant
F2 52 M 74 Stomach Adenocarcinoma III Malignant
F3 53 M 62 Esophagus Smooth muscle and phlegmasia - Malignant
F4 54 M 54 Kidney Clear cell carcinoma - Malignant
F5 55 F 47 Brain Syncytial meningioma - Benign
F6 56 F 42 Uterus Smooth muscle and phlegmasia - Normal
F7 57 M 38 Tongue Adenoid cystic carcinoma - Malignant
F8 58 M 58 Colon Adenocarcinoma I Malignant
F9 59 F 65 Breast Infiltrating duct carcinoma - Malignant
F10 60 M 57 Lung Adenocarcinoma III Malignant
, . † For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

Staining Scoring: '-' - no staining; '+-' - borderline staining; '+' - weak staining; '++' - moderate staining; '+++' - strong staining; '%' - percentage of positive cells.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis
Home
Products
Contact Us
About Us

E-mail:

Password:

My Account
Cart (0 items)
$0.00